We are really proud to become an important part of Quanterix Corp. The merger between the companies hold great promise to truly unlocking the value of NF-L. We are compelled by Quanterix’ vision, mission, and strategy for disrupting the field of neurodegeneration research and diagnostics and are confident in the management team’s ability to continue its superb execution against this substantial opportunity.
You can read more about the merger here.
